Answers are grounded in this paper and cite their sources.
People who use drugs experience stigma due to their substance use and for those who are living with HIV also experience stigma due to their HIV status. Stigma acts as a barrier to healthcare access, contributing to negative health outcomes and a diminished quality of life (QOL). In this systematic review, we aimed to assess the associations of drug use and HIV stigma with QOL among people who use drugs globally. The systematic review protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) with registration number of CRD42020209816. In accordance with the protocol, we searched MEDLINE (Ovid), CINAHL Plus with Full Text (Ebsco), The Cochrane Library (Wiley), EMBASE (Elsevier), and PsycInfo (Ebsco) from inception of the databases to 2026. We conducted a narrative synthesis of studies examining how drug use and HIV stigma impact the QOL of individuals currently using drugs or in treatment for substance use disorders. Studies in English language from all countries were eligible for inclusion. Fourteen studies were included in this systematic review, all of which had a cross-sectional design. Twelve studies reported on drug use stigma and two focused on HIV stigma; however, no single study investigated both. Most of the included studies were conducted in North America and Asia; none were retrieved from Africa or South America. We observed significant heterogeneity in the instruments used to measure stigma and QOL. The reviewed studies indicated that drug use stigma is associated with lower QOL among people who use drugs; however, their cross-sectional design limit causal inference. Meanwhile, the two studies examining HIV stigma and QOL yielded mixed results. These findings highlight the need to design interventions that address drug use stigma. In addition, studies with stronger study designs such as randomized controlled trials, quasi-experimental, longitudinal, and prospective should be conducted in various geographical areas to obtain evidence on the causality between stigma (HIV and drug use stigma) and QOL among people who use drugs.
No takes yet. Share an insight, caveat, or question.
Mlunde et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: